Shpall EJ - Search Results

1

Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.

Nieto Y, Cagnoni PJ, Shpall EJ, Matthes S, Barón A, Jones RB, Bearman SI. Nieto Y, et al. Among authors: shpall ej. Clin Cancer Res. 1999 Jul;5(7):1731-7. Clin Cancer Res. 1999. PMID: 10430076 Clinical Trial.

2

Treatment of breast cancer in the 1990s. What does the future hold?

Jones RB, Shpall EJ. Jones RB, et al. Among authors: shpall ej. Drugs. 1992 Feb;43(2):141-5. doi: 10.2165/00003495-199243020-00001. Drugs. 1992. PMID: 1372213 Review. No abstract available.

3

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO. Peters WP, et al. Among authors: shpall ej. J Clin Oncol. 1988 Sep;6(9):1368-76. doi: 10.1200/JCO.1988.6.9.1368. J Clin Oncol. 1988. PMID: 3047332

4

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.

Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, et al. Shpall EJ, et al. J Clin Oncol. 1994 Jan;12(1):28-36. doi: 10.1200/JCO.1994.12.1.28. J Clin Oncol. 1994. PMID: 7505806

5

New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.

Shpall EJ, Stemmer SM, Bearman SI, Myers S, Purdy M, Jones RB. Shpall EJ, et al. Breast Cancer Res Treat. 1993;26 Suppl:S19-23. doi: 10.1007/BF00668356. Breast Cancer Res Treat. 1993. PMID: 7691269 Clinical Trial.

6

High-dose therapy with autologous bone marrow transplantation for the treatment of solid tumors.

Shpall EJ, Jones RB, Bearman S. Shpall EJ, et al. Curr Opin Oncol. 1994 Mar;6(2):135-8. doi: 10.1097/00001622-199403000-00004. Curr Opin Oncol. 1994. PMID: 8011690 Review.

7

Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow support.

Shpall EJ, Jones RB, Bearman SI, Purdy MP. Shpall EJ, et al. Gynecol Oncol. 1994 Sep;54(3):357-61. doi: 10.1006/gyno.1994.1223. Gynecol Oncol. 1994. PMID: 8088613 Clinical Trial.

8

Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.

Shpall EJ, Stemmer SM, Hami L, Franklin WA, Shaw L, Bonner HS, Bearman SI, Peters WP, Bast RC Jr, McCulloch W, et al. Shpall EJ, et al. Blood. 1994 Jun 1;83(11):3132-7. Blood. 1994. PMID: 8193351 Free article. Clinical Trial.

9

Role of autotransplantation in treatment of other solid tumors.

Shpall EJ, Stemmer SM, Bearman SI, Jones RB. Shpall EJ, et al. Hematol Oncol Clin North Am. 1993 Jun;7(3):663-86. Hematol Oncol Clin North Am. 1993. PMID: 8344885 Review.

10

Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer.

Jones RB, Matthes S, Dufton C, Bearman SI, Stemmer SM, Meyers S, Shpall EJ. Jones RB, et al. Among authors: shpall ej. Breast Cancer Res Treat. 1993;26 Suppl:S11-7. doi: 10.1007/BF00668355. Breast Cancer Res Treat. 1993. PMID: 8400329 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters